Farallon Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,188,000	Closed	-$180M	–	150
2024 Q4	$180M	Buy	+3,188,000	New	+$178M	0.95%	42
2021 Q1	–	Sell	-250,000	Closed	-$15.5M	–	239
2020 Q4	$15.5M	Sell	250,000 -3,500,000	-93%	-$215M	0.1%	97
2020 Q3	$226M	Buy	3,750,000 +125,000	+3%	+$7.52M	1.6%	24
2020 Q2	$213M	Buy	+3,625,000	New	+$217M	1.71%	21
2018 Q1	–	Sell	-1,192,500	Closed	-$73.1M	–	92
2017 Q4	$73.1M	Sell	1,192,500 -162,500	-12%	-$10.2M	0.73%	34
2017 Q3	$86.4M	Buy	+1,355,000	New	+$79.1M	0.9%	34
2017 Q2	–	Sell	-442,500	Closed	-$24.1M	–	84
2017 Q1	$24.1M	Buy	442,500 +132,500	+43%	+$7.27M	0.3%	52
2016 Q4	$18.1M	Buy	+310,000	New	+$16.9M	0.27%	46